CRISPR/cas9-mediated recombination created a 5 bp deletion (CTGTG) followed by a 1 bp (A) insertion in exon 1 upstream of the catalytic threonine (T43) resulting in a frameshift mutation and premature stop codon upstream of the catalytic threonine. Western blot analysis confirmed the absence of expression in brains from homozygous mice.